Open Access Research article

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

Rosarin Sruamsiri1, Nathorn Chaiyakunapruk1234*, Samart Pakakasama5, Somtawin Sirireung5, Nintita Sripaiboonkij6, Udomsak Bunworasate7 and Suradej Hongeng5*

Author Affiliations

1 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand

2 School of Population Health, University of Queensland, Brisbane, Australia

3 School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA

4 Jeffrey Cheah School of Medicine and Health Sciences, Monash University Sunway campus, Monash, Malaysia

5 Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

6 Cancer registry unit, health case management services, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

7 Department of Medicine, Faculty of Medicine, Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand

For all author emails, please log on.

BMC Health Services Research 2013, 13:45  doi:10.1186/1472-6963-13-45

Published: 5 February 2013

There is no additional files for this article.